Search

Search bills, members, committees and pages...

AMGEN

96 federal lobbying filings, 2023 to 2026.

AMGEN is a client on 96 federal lobbying filings, 2023 to 2026, reporting $3.9M across them. Pharmaceutical company Based in District of Columbia.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

10 it has hired, by filings.

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
202615$638K
202529$1.3M
202423$956K
202329$983.5K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
MMMMedicare/Medicaid47
HCRHealth Issues42
TAXTaxation/Internal Revenue Code31
PHAPharmacy17
CPTCopyright/Patent/Trademark14
TRDTrade (domestic/foreign)4
ECNEconomics/Economic Development2
GOVGovernment Issues2

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.6
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…3
H.R. 1990American Innovation and R&D Competitiveness Act of 20253
H.R. 946ORPHAN Cures Act2
S. 1862ORPHAN Cures Act2
S. 3788CLEAR LABELS Act2
S. 839Safeguarding Honest Speech Act2
H.R. 1968Full-Year Continuing Appropriations and Extensions Act, 20251
H.R. 5526Biosimilar Red Tape Elimination Act1
S. 1954Biosimilar Red Tape Elimination Act1
S. 2658Medication Affordability and Patent Integrity Act1
S. 3014Ensuring Timely Access to Generics Act of 20251

Lobbyists

Named on the filings.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
AMGENMR. DAN CRIPPEN2026 second_quarterJul 28, 2026
AMGENTHE NICKLES GROUP, LLC2026 second_quarter$60KJul 20, 2026
AMGENSIGHTLINE ADVOCACY, LLC2026 second_quarter$20KJul 20, 2026
AMGENTHE MCMANUS GROUP2026 second_quarter$60KJul 20, 2026
AMGENCAPITOL 6 ADVISORS2026 second_quarter$60KJul 20, 2026
AMGENALPINE GROUP PARTNERS, LLC.2026 second_quarter$50KJul 17, 2026
AMGENCAPITOL TAX PARTNERS, LLP2026 second_quarter$60KJul 16, 2026
AMGENPANNONE LOPES DEVEREAUX & O'GARA LLC2026 second_quarter$9KJul 2, 2026
AMGENTHE NICKLES GROUP, LLC2026 first_quarter$60KApr 20, 2026
AMGENCAPITOL 6 ADVISORS2026 first_quarter$60KApr 20, 2026
AMGENCAPITOL TAX PARTNERS, LLP2026 first_quarter$60KApr 20, 2026
AMGENTHE MCMANUS GROUP2026 first_quarter$60KApr 20, 2026
AMGENALPINE GROUP PARTNERS, LLC.2026 first_quarter$50KApr 19, 2026
AMGENSIGHTLINE ADVOCACY, LLC2026 first_quarter$20KApr 18, 2026
AMGENPANNONE LOPES DEVEREAUX & O'GARA LLC2026 first_quarter$9KApr 7, 2026
AMGENMR. DAN CRIPPEN2025 fourth_quarter$100KFeb 18, 2026
AMGENTHE NICKLES GROUP, LLC2025 fourth_quarter$60KJan 20, 2026
AMGENCAPITOL 6 ADVISORS2025 fourth_quarter$60KJan 20, 2026
AMGENTHE MCMANUS GROUP2025 fourth_quarter$60KJan 20, 2026
AMGENCAPITOL TAX PARTNERS, LLP2025 fourth_quarter$60KJan 20, 2026
AMGENALPINE GROUP PARTNERS, LLC.2025 fourth_quarter$50KJan 20, 2026
AMGENSIGHTLINE ADVOCACY, LLC2025 fourth_quarter$20KJan 20, 2026
AMGENPANNONE LOPES DEVEREAUX & O'GARA LLC2025 fourth_quarter$9KJan 12, 2026
AMGENSIGHTLINE ADVOCACY, LLC2025 fourth_quarterNov 17, 2025
AMGENPANNONE LOPES DEVEREAUX & O'GARA LLC2025 third_quarter$9KNov 6, 2025